CHA ÀǰúÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • À̼¼Èñ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : È£Èí±âÁúȯ
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
53 (±¹¿Ü)SCI Impaired Colony-Forming Capacity of Circulating EndothelialProgenitor Cells in Patients with Emphysema
52 (±¹³»)SCOPUS A Case of Human Herpes Virus-8 Unrelated Primary EffusionLymphoma-Like Lymphoma Presented as Pleural Effusion
51 (±¹¿Ü)SCI Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke induced damage
50 (±¹¿Ü)SCI Lung mast cell density defines a subpopulation of patientswith idiopathic pulmonary fibrosis
49 (±¹³»)SCI Comparison of Clinico-Physiologic and CT Imaging Risk Factorsfor COPD Exacerbation
48 (±¹¿Ü)SCIE YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
47 (±¹¿Ü)SCI Imbalance of Apoptosis and Cell Proliferation Contributes to the Development and Persistence of Emphysema.
46 (±¹³»)SCOPUS Lack of Association between the Klotho Gene and COPD
45 (±¹¿Ü)SCI CIGARRETTE SMOKE INDUCES AKT DEGRADATION BY THE UBIQUITIN PROTEASOME SYSTEM
44 (±¹¿Ü)SCI Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 18 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾Çհǰ­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729